Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.
Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy. Cancer Immunol Res. 2021 05; 9(5):568-582.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
CD8-Positive T-Lymphocytes
Cell Line, Tumor
Female
Humans
Immunity
Immunotherapy
Melanoma
Mice
Mice, Inbred C57BL
Programmed Cell Death 1 Receptor
Sphingomyelin Phosphodiesterase
Th1 Cells
authors with profiles
Yusuf A. Hannun